Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)
9.00
+0.10 (1.12%)
At close: Apr 15, 2026
Central Pharmaceuticals Revenue
Central Pharmaceuticals had revenue of 9.06M BDT in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to 34.45M, up 390.88% year-over-year. In the fiscal year ending June 30, 2025, Central Pharmaceuticals had annual revenue of 33.06M with 11.68% growth.
Revenue (ttm)
34.45M
Revenue Growth
+390.88%
P/S Ratio
31.29
Revenue / Employee
465.60K
Employees
74
Market Cap
1.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 33.06M | 3.46M | 11.68% |
| Jun 30, 2024 | 29.60M | 271.46K | 0.93% |
| Jun 30, 2023 | 29.33M | 3.33M | 12.81% |
| Jun 30, 2022 | 26.00M | -122.15M | -82.45% |
| Jun 30, 2021 | 148.15M | 8.06M | 5.75% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The IBN SINA Pharmaceutical Industry | 13.42B |
| Navana Pharmaceuticals | 10.07B |
| Techno Drugs | 3.15B |
| Orion Pharma | 3.12B |
| Advent Pharma | 516.48M |
| Pharma Aids | 474.48M |
| Silco Pharmaceuticals | 431.04M |
| Silva Pharmaceuticals | 356.99M |